Bainian Yihao
Chengdu
About Bainian Yihao
Established in 2017, the 100-year nickname is positioned in the transformation of biomedical innovations and new drug research and development institutions, mainly for the development of new drugs such as CAR-T cell therapy and tumor vaccines, such as immunotherapy, gene therapy, stem cell therapy and small molecule targeted drugs. .
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $22.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2019)
Industries & Categories
Biotechnology, Health Care, Hospital, Medical
Canonical: https://fsome.com/organization/bainian-yihao-1420 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.